Lorch, U
53  Ergebnisse:
Personensuche X
?
1

PB0228 A Prospective, Observational Study of Bleeding and Q..:

Lorch, U. ; York, T. ; Khair, K...
Research and Practice in Thrombosis and Haemostasis.  7 (2023)  - p. 101263 , 2023
 
?
2

Novel antisense therapy targeting microRNA-132 in patients ..:

Taubel, J ; Hauke, W ; Rump, S...
European Heart Journal.  42 (2021)  Supplement_1 - p. , 2021
 
?
3

The practical application of adaptive study design in early..:

Lorch, U. ; Berelowitz, K. ; Ozen, C....
European Journal of Clinical Pharmacology.  68 (2011)  5 - p. 543-551 , 2011
 
?
4

The Reliability of Auto-Injectors in Clinical Use: A System..:

Dostal, P ; Taubel, J ; Lorch, U..
https://openaccess.sgul.ac.uk/id/eprint/115619/1/20230808-1909-1iv4uzw.pdf.  , 2023
 
?
5

Molnupiravir versus placebo in unvaccinated and vaccinated ..:

Khoo, SH ; FitzGerald, R ; Saunders, G...
https://eprints.whiterose.ac.uk/193234/7/1-s2.0-S1473309922006442-main.pdf.  , 2022
 
?
6

Concentration-QT modelling of the novel DHFR inhibitor P218..:

Täubel, J ; Lorch, U ; Ferber, G...
https://openaccess.sgul.ac.uk/id/eprint/115595/1/Concentration-QT%20modelling%20of%20the%20novel%20DHFR%20inhibitor%20P218%20in%20healthy%20male%20volunteers.pdf.  , 2022
 
?
7

Confirmation of the cardiac safety of nolasiban in a random..:

Täubel, J ; Lorch, U ; Spencer, CS...
https://openaccess.sgul.ac.uk/id/eprint/115596/1/Confirmation%20of%20the%20cardiac%20safety%20of%20nolasiban%20in%20a%20randomised%20cohort%20of%20healthy%20female%20volunteers.pdf.  , 2021
 
?
8

First-in-human clinical trial to assess the safety, tolerab..:

Chughlay, MF ; Rossignol, E ; Donini, C...
https://openaccess.sgul.ac.uk/id/eprint/114003/1/First-in-human%20clinical%20trial%20to%20assess%20the%20safety,%20tolerability%20and%20pharmacokinetics%20of%20P218,%20a%20novel%20candidate%20for%20malaria.pdf.  , 2020
 
?
10

Time- and Race-Specific Haematological Reference Intervals ..:

Coates, S ; Wang, D ; Pierscionek, T...
https://openaccess.sgul.ac.uk/id/eprint/114004/1/Time-%20and%20Race-Specific%20Haematological%20Reference%20Intervals%20for%20Healthy%20Volunteer%20Trials%20A%20Retrospective%20Analysis%20of%20Pooled%20D.pdf.  , 2020
 
?
11

Thorough QT study of the effect of intravenous amisulpride ..:

Täubel, J ; Ferber, G ; Fox, G...
https://openaccess.sgul.ac.uk/id/eprint/108271/7/bcp13128.pdf.  , 2017
 
?
12

Pharmacokinetics, Safety and Cognitive Function Profile of ..:

Täubel, J ; Ferber, G ; Fernandes, S...
https://openaccess.sgul.ac.uk/id/eprint/114098/1/Pharmacokinetics,%20Safety%20and%20Cognitive%20Function%20Profile%20of%20Rupatadine%2010,%2020%20and%2040%20mg%20in%20Healthy%20Japanese%20Subjects%20A%20Random.pdf.  , 2016
 
?
13

Single Doses up to 800 mg of E-52862 Do Not Prolong the QTc..:

Täubel, J ; Ferber, G ; Lorch, U...
https://openaccess.sgul.ac.uk/id/eprint/107757/1/Single%20Doses%20up%20to%20800%20mg%20of%20E-52862%20Do%20Not%20Prolong%20the%20QTc%20Interval--A%20Retrospective%20Validation%20by%20Pharmacokinetic-Pharmacodynamic%20Modelling%20of%20Electrocardiography%20Data%20Utilising%20the%20Effects%20of%20a%20Meal%20on%20QTc%20to%20Demonstrate%20ECG%20Assay%20Sensitivity.pdf.  , 2015
 
?
14

The Power of Phase I Studies to Detect Clinical Relevant QT..:

Ferber, G ; Lorch, U ; Täubel, J
https://openaccess.sgul.ac.uk/id/eprint/114097/1/The%20Power%20of%20Phase%20I%20Studies%20to%20Detect%20Clinical%20Relevant%20QTc%20Prolongation%20A%20Resampling%20Simulation%20Study.pdf.  , 2015
 
1-15
Mehr Literatur finden